Patients With Severe Acute Exacerbation of COPD Ans Admitted in ICU Register.

Recruiting now

Conditions studied: COPD Exacerbation

In brief

The objective of this prospective observational study is to describe the epidemiological, clinical and biological characteristics of admitted patients in ICU for severe acute exacerbation of COPD, to assess the different therapeutics used, to evaluate the prognosis of patients with short, medium and long term ( 1 year) and the various factors associated with survival in ICU

Key facts

Study ID

NCT06257329

Run by

Alexis FERRE

People needed

2000

Starts

2022-10-01

Expected to finish

2028-04-01

Last updated by the study team

2024-02-13

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 40 years old
• COPD documented or strongly suspected
• Chronic respiratory symptoms (dyspnoea, cough and/or sputum)
• Exposure to a known risk factor for COPD (such as tobacco smoke)
• If available, respiratory function tests showing non- or partially reversible obstructive syndrom (post-bronchodilator ratio FEV1/CV < 0.7)
• Severe acute exacerbation, defined as a worsening of the patient's usual respiratory symptoms with signs of acute respiratory distress (polypnoea ≥ 30 cycles.min-1 or use of accessory respiratory muscles) and/or hypercapnic acidosis (with PaCO2 ≥ 45 mmHg and pH ≤ 7.35)
• Admission to an ICU, a step-up unit or a respiratory care unit

You may not qualify if…

• Known asthma (according to the criteria of the international "Global initiative for asthma" guidelines)
• Patient refusal to participate (information note, application for non-opposition)

Where it is running

• Centre hospitalier de Versailles — Le Chesnay, France (enrolling)
• CH Le Mans — Le Mans, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.